Antimicrobial resistance has become a major challenge in our globalised world and tackling it will take the combined resources and effort of researchers working across different disciplines. This conference will bring together basic researchers, computer scientists, clinicians and policy makers interested in pathogen and human/host genomics, epidemiology and surveillance, machine learning, development of novel diagnostic tools and translation of AMR-data into clinical practice to discuss their findings.
Technical advances in recent years continue to expand our ability to collect huge amounts of genomic information on pathogens and their hosts, and a wealth of data is being collected in epidemiological and surveillance studies, including on the socio-economic burden of AMR.
This year the conference will highlight the role of genomic evidence – from internal and external environments as well as its role in the detection, tracking and control of antimicrobial resistance, especially in low- and middle-income countries. We will also discuss the role of vaccines in AMR and how bacterial genomics and metagenomics can be translated into clinical practice.